Mahlangu JN, Lamas JL, Morales JC, Malan DR, Šalek SZ, Wang M, et al. A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia. Br J Haematol. 2023;200(2):229-39. https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.18420
A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia.
By Peter Matlawa|2023-02-23T09:08:57+02:00February 23, 2023|2022: July to September|Comments Off on A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia.
Share This Story, Choose Your Platform!
About the Author: Peter Matlawa
Related Posts
Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys(®) cortisol II assay: a pilot study.